Catalyst Wire Dossier Catalyst Wire Dossier

CVT-301 (levodopa inhalation powder)

levodopa inhalation powder · Acorda Therapeutics
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CVT-301 (levodopa inhalation powder), covering 2016-06-13 to 2017-01-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder) [Phase 1]

See pricing